Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D9EC0G
|
|||
Drug Name |
Zemaira
|
|||
Synonyms |
Alpha-1-antitrypsin
Click to Show/Hide
|
|||
Drug Type |
Recombinant protein
|
|||
Indication | Emphysema [ICD-11: CA21; ICD-9: 492] | Approved | [1] | |
Company |
CSL Behring
|
|||
ADReCS Drug ID | BADD_D00084 |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Alpha-1-antitrypsin (SERPINA1) | Target Info | Inhibitor | [1] |
KEGG Pathway | Complement and coagulation cascades | |||
NetPath Pathway | IL6 Signaling Pathway | |||
Panther Pathway | Blood coagulation | |||
Pathway Interaction Database | p73 transcription factor network | |||
FOXA1 transcription factor network | ||||
Reactome | Platelet degranulation | |||
COPII (Coat Protein 2) Mediated Vesicle Transport | ||||
Cargo concentration in the ER | ||||
WikiPathways | Complement and Coagulation Cascades | |||
NRF2 pathway | ||||
Nuclear Receptors Meta-Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.